Histologic Findings and Clinical Characteristics in Acutely Symptomatic Ulcerative Colitis Patients with Superimposed Clostridium difficile Infection

American Journal of Clinical Pathology

Volumn 140, Issue 6, 2013, Pages 831-837

  Wang, Tao ^a   Matukas, Larissa ^a,b   Streutker, Catherine J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Clostridium difficile; Pseudomembranes; Ulcerative colitis

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; ISCHEMIA; LAMINA PROPRIA; MALE; MUCOSAL BLEEDING; PREDICTIVE VALUE; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

CLOSTRIDIUM DIFFICILE; PSEUDOMEMBRANES; ULCERATIVE COLITIS;

ADULT; AGED; CLOSTRIDIUM DIFFICILE; COLITIS, ULCERATIVE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84888232785     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP2LBRTTJBF3KD     Document Type: Article

References (14)

1. Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1432-1442.
2. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443-1450.
3. Kariv R, Navaneethan U, Venkatesh PG, et al. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohns Colitis. 2011;5:34-40
4. Lamps L. Infectious disorders of the GI tract. In: Odze R, Goldblum J, eds. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. 2nd ed. Philadelphia, PA: Saunders Elsevier; 2009:51-79.
5. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385.
6. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci. 2010;55:415-420.
7. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345-351.
8. Petras R, Gramlich TL. Nonneoplastic intestinal diseases. In: Mills SE, ed. Sternberg's Diagnostic Surgical Pathology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:1313-1367.
9. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235:363-372.
10. Gebhard RL, Gerding DN, Olson MM, et al. Clinical and endoscopic findings in patients early in the course of Clostridium difficile-associated pseudomembranous colitis. Am J Med. 1985;78:45-48.
11. Bossuyt P, Verhaegen J, Van Assche G, et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2009;3:4-7.
12. Nomura K, Fujimoto Y, Yamashita M, et al. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents. Scand J Gastroenterol. 2009;44:74-78.
13. Planche T, Aghaizu A, Holliman R, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis. 2008;8:777-784.
14. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-455